Please use this identifier to cite or link to this item: https://doi.org/10.3389/fpsyt.2019.00743
DC FieldValue
dc.titleEffects of opioid dependence on visuospatial memory and its associations with depression and anxiety
dc.contributor.authorTolomeo, S.
dc.contributor.authorDavey, F.
dc.contributor.authorSteele, J.D.
dc.contributor.authorBaldacchino, A.M.
dc.date.accessioned2021-12-09T04:56:36Z
dc.date.available2021-12-09T04:56:36Z
dc.date.issued2019
dc.identifier.citationTolomeo, S., Davey, F., Steele, J.D., Baldacchino, A.M. (2019). Effects of opioid dependence on visuospatial memory and its associations with depression and anxiety. Frontiers in Psychiatry 10 (OCT) : 743. ScholarBank@NUS Repository. https://doi.org/10.3389/fpsyt.2019.00743
dc.identifier.issn1664-0640
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/210042
dc.description.abstractIntroduction: The cognitive impact of opioid dependence is rarely measured systematically in everyday clinical practice even though both patients and clinicians accept that cognitive symptoms often occur in the opioid-dependent population. There are only a few publications which utilized computerized neuropsychological tests to assess possible impairments of visuospatial memory in opioid-dependent individuals either receiving opioid replacement therapy (ORT) or during subsequent short-term abstinence and the effects of anxiety and depression. Methods: We assessed a cohort of 102 participants, comprising i) a stable opioid-dependent group receiving methadone maintenance treatment (MMT) (n = 22), ii) a stable opioid-dependent group receiving buprenorphine (BMT) (n = 20), iii) a current abstinent but previously opioid-dependent group (ABS) (n = 8), and iv) a control group who have never been dependent on opioids. The Cambridge Neuropsychological Automated Test Battery (CANTAB) neuropsychological tasks undertaken by participants included: Delayed Matching to Sample (DMS), Pattern Recognition Memory (PRM), Spatial Recognition Memory (SRM), and Paired Associate Learning (PAL) tasks. Three clinical measures were used to assess the severity of anxiety and depressive illness: Hospital Anxiety Scale-Hospital Anxiety Depression (HADA)-(HADD), Beck Depression Inventory (BDI), and Inventory of Depressive Symptomatology (self-report) (ISD-SR). Results: The methadone-and buprenorphine-treated groups showed significant impairments (p < 0.001) in visuospatial memory tasks but not the abstinent group. Impairments in visuospatial memory strongly correlated with higher mood and anxiety symptom severity scores (p < 0.001). Discussion: These results are broadly consistent with previous studies. Uniquely, though, here we report a strong relationship between visuospatial memory and depression and anxiety scores, which might suggest common illness mechanisms. © 2019 Tolomeo, Davey, Steele and Baldacchino.
dc.publisherFrontiers Media S.A.
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceScopus OA2019
dc.subjectAnxiety
dc.subjectBuprenorphine
dc.subjectDepression
dc.subjectHeroin
dc.subjectmemory
dc.subjectMethadone
dc.subjectOpioid dependence
dc.typeArticle
dc.contributor.departmentDEAN'S OFFICE (ARTS & SOCIAL SC.)
dc.description.doi10.3389/fpsyt.2019.00743
dc.description.sourcetitleFrontiers in Psychiatry
dc.description.volume10
dc.description.issueOCT
dc.description.page743
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3389_fpsyt_2019_00743.pdf920.35 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons